Skip to main content
Panacea Biotec Ltd. logo

Panacea Biotec Ltd. — Investor Relations & Filings

Ticker · PANACEABIO ISIN · INE922B01023 LEI · 3358001FA81ZQYDLO796 BSE.NS Manufacturing
Open in API
Filings indexed 793 across all filing types
Latest filing 2023-08-14 Regulatory Filings
Country IN India
Listing BSE.NS PANACEABIO

About Panacea Biotec Ltd.

https://www.panaceabiotec.com

Panacea Biotec Ltd. is a research-driven health management company specializing in the development, manufacturing, and marketing of vaccines, biopharmaceuticals, and pharmaceutical formulations. The organization focuses on therapeutic segments including organ transplantation, nephrology, oncology, diabetes, and pain management. Its vaccine portfolio supports global immunization initiatives, addressing diseases such as polio and hepatitis B through partnerships with international health agencies. The company operates integrated research and development centers and manufacturing facilities that adhere to international quality standards. Panacea Biotec emphasizes the creation of innovative drug delivery systems and complex generics to improve patient outcomes. Its operations are characterized by a commitment to biotechnology-led medical solutions and the production of affordable, high-quality therapeutic products for diverse global markets.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document contains a letter addressed to stock exchanges regarding compliance under SEBI regulations about unaudited standalone and consolidated financial results for the quarter ended June 30, 2023. It mentions the approval of these provisional financial results and includes newspaper extracts of the statement of unaudited financial results. The document also includes a notice about the 35th Annual General Meeting (AGM) of Varroc Engineering Limited, scheduled for September 13, 2023, with details about electronic voting and the dispatch of the AGM Notice and Annual Report for FY 2022-23. However, the document itself does not contain the full financial results or the full annual report but rather announcements and notices related to these events. The length is 15,000 characters, which is substantial, but the content is primarily announcements and notices rather than the full reports. According to the "Menu vs Meal" rule, since the document is an announcement of the unaudited financial results and AGM notice rather than the full report, it should be classified as Regulatory Filings (RNS).
2023-08-14 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges regarding the re-classification of certain shareholders from the 'Promoter & Promoters' Group' category to the 'Public' category. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 31A. The document includes a certified true copy of the Board resolution approving this re-classification. There are no financial statements, earnings data, or detailed financial analysis present. The content is regulatory in nature, focusing on shareholding classification changes and compliance filings. This fits the category of a Regulatory Filing (RNS) as it is a compliance disclosure and does not constitute a financial report or announcement of voting results. The document length and detail also support this classification rather than a brief announcement or a full report.
2023-08-12 English
Financial Result Updates
Regulatory Filings
2023-08-12 English
Outcome of Board Meeting
Regulatory Filings
2023-08-12 English
Updates
Major Shareholding Notification Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a request from certain shareholders to reclassify their shareholding status from 'Promoter & Promoters’ Group' to 'Public' category. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, specifically Regulation 31A. The content is an announcement of a corporate action related to shareholding classification and does not contain financial statements, earnings data, or detailed report content. The document length is short (2371 characters) and it is an announcement rather than a report. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or classifications.
2023-08-10 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges and depositories regarding the details of shares dematerialized during July 2023. It references Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, and includes annexures with data on shares dematerialized. The document is essentially an update or notification about share dematerialization status, including a certificate from the registrar and share transfer agent. It does not contain financial statements, management discussion, or detailed financial results. It is not a report like an Annual Report, Interim Report, or Earnings Release. It is also not a proxy, voting result, or governance document. The document is a regulatory compliance filing providing information to stock exchanges and depositories. Given its nature and length (4196 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-08-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.